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While performing a literature search in PubMed on applica-
tion of PK/PD parameters in veterinary, we found the review
“Application of PK/PD Modeling in Veterinary Field: Dose
Optimization and Drug Resistance Prediction” by Ahmad
et al. published in BioMed Research International [1]. This
review deals with antimicrobial drugs used in veterinary and
with pharmacokinetic/pharmacodynamic modeling devel-
oped to maximize drug efficacy, establish appropriate dosage
regimens, and reduce side effects.
Although the review is interesting and well-articulated,
we disagree with the content of Table 3.
In that table (page 5) the different classes of antimi-
crobial drugs are divided into two groups. For group 1 the
common criterion is the AUC/MIC ratio (𝐶max/MIC or
AUC
0–24/MIC). For group 2, %𝑇>MIC is the classification cri-
terion. The table is indeed inspired by a previous publication
by Martinez et al. published in 2012 [2]. The grouping of
antibiotics based on PK/PD parameters is also discussed by
Martinez et al. in 2014 [3], by Ambrose et al. in 2007 [4], and
by several other authors.
In all cases Ketolides, Lincosamides (clindamycin), and
Glycopeptides (Vancomycin) are identified by the AUC/MIC
ratio as PK/PD reference parameters. They should therefore
be included in group 1 and not in group 2 as done by the
authors of the review published in your journal.
Those antibiotics have effects that are time dependent
but this is not a sufficient criterion to apply as PK/PD crite-
rion %𝑇
>MIC. Indeed, antimicrobial efficacy of Vancomycin,
Clindamycin, and Telithromycin is related to 𝐶max/MIC or
AUC
0–24/MIC.
It is well known that antimicrobial agents that interact
with the cell wall usually display time-dependent bacterici-
dal activity that correlates with %𝑇
>MIC. On the contrary,
agents that inhibit protein synthesis have a concentration-
dependent bactericidal action which correlates well with
the AUC/MIC ratio. Thus, Ketolides and Lincosamides are
usually included in group 1 and not 2 (see [2, 3]).
However it should be noted that also agent acting on
the bacterial wall may be included in group 1 (bactericidal
action correlating more with the AUC/MIC ratio than with
the %𝑇
>MIC). In the case of Vancomycin, whose half-life and
prolonged PAE fully satisfy the condition time-dependent
bactericidal effect, the real predictor of efficacy ismore closely
related to plasma concentration [5, 6].
The implication of including an agent in group 1 or 2
is definition of the therapy in terms of dose and pharma-
cokinetics. Including one agent in one group instead of the
other is not trivial and may lead to therapeutic errors. We
therefore strongly recommend that the organization of Table
3 is revised according to our observation and to the abundant
literature.
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